Hospira
Hospira takes charge of biogeneric Neupogen
October 14, 2009Sales and Marketing Hospira, biosimilars, generics
US pharmaceutical company Hospira has acquired worldwide rights to a biogeneric version of Amgen's neutropenia treatment Neupogen (filgrastim) in a …
Latest content
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
